Pharma Mar | PHM - Stammkapital

Aktienkurs
93.00
Täglich Wechseln
0.60 0.65%
Monatlich
11.11%
Jährlich
21.57%
Q2 Prognose
90.46




Stammkapital Veränderung Datum
Akebia Therapeutics USD 265.42M 199K 2025-12
Alaunos Therapeutics USD 2.21M 131K 2025-09
Almirall EUR 214.79M 0 2025-12
Dianthus Therapeutics USD 43.22M 368.53K 2025-12
Ionis Pharmaceuticals USD 161.97M 836K 2025-12
IQVIA Holdings USD 169.6M 700K 2025-12
Laboratorios Farma EUR 51.82M 1.55M 2023-12
Moderna USD 391M 2M 2025-09
Organon & Co USD 259.98M 18K 2025-09
Pharma Mar EUR 17.36M 214.99K 2025-12
Revvity USD 113.38M 2.7M 2025-12
Tectonic Therapeutic USD 18.74M 25.03K 2025-12
Viatris USD 1.16B 6.55M 2025-09
Xeris Pharmaceuticals USD 166.22M 687.16K 2025-12